Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA,
Qual Life Res. 2013 Nov;22(9):2389-98. doi: 10.1007/s11136-013-0363-3. Epub 2013 Mar 21.
To evaluate effects of two behavioral weight-loss interventions (in-person, remote) on health-related quality of life (HRQOL) compared to a control intervention.
Four hundred and fifty-one obese US adults with at least one cardiovascular risk factor completed five measures of HRQOL and depression: MOS SF-12 physical component summary (PCS) and mental component summary; EuroQoL-5 dimensions single index and visual analog scale; PHQ-8 depression symptoms; and PSQI sleep quality scores at baseline and 6 and 24 months after randomization. Change in each outcome was analyzed using outcome-specific mixed-effects models controlling for participant demographic characteristics.
PCS-12 scores over 24 months improved more among participants in the in-person active intervention arm than among control arm participants (P < 0.05, ES = 0.21); there were no other statistically significant treatment arm differences in HRQOL change. Greater weight loss was associated with improvements in most outcomes (P < 0.05 to < 0.0001).
Participants in the in-person active intervention improved more in physical function HRQOL than participants in the control arm did. Greater weight loss during the study was associated with greater improvement in all PRO except for sleep quality, suggesting that weight loss is a key factor in improving HRQOL.
与对照干预相比,评估两种行为减肥干预(面对面、远程)对健康相关生活质量(HRQOL)的影响。
451 名患有至少一种心血管危险因素的美国肥胖成年人完成了五项 HRQOL 和抑郁评估:MOS SF-12 生理成分综合评分(PCS)和心理成分综合评分;EuroQoL-5 维度单一指数和视觉模拟评分;PHQ-8 抑郁症状评分;以及随机分组后 6 个月和 24 个月时的 PSQI 睡眠质量评分。使用特定于结局的混合效应模型,根据参与者的人口统计学特征,对每种结局的变化进行分析。
在 24 个月时,面对面积极干预组参与者的 PCS-12 评分比对照组参与者提高更多(P<0.05,ES=0.21);HRQOL 变化在其他治疗组之间没有其他统计学显著差异。体重减轻更多与大多数结局的改善相关(P<0.05 至<0.0001)。
面对面积极干预组的参与者在生理功能 HRQOL 方面的改善优于对照组。在研究期间体重减轻更多与除睡眠质量外所有 PRO 的改善更大相关,这表明体重减轻是改善 HRQOL 的关键因素。